Life Science Equipment Market Growth Overview
Meticulous Research®—a leading global market research company, published a research report titled, Life Science Equipment Market Size, Share, Forecast, & Trends Analysis By Technology (Spectroscopy, Microscopy, Chromatography (HPLC, GC, TLC), PCR, Immunoassay, Sequencing, Flow Cytometry, Microarray, Centrifuge) End User – Global Forecast to 2031.’
According to this latest
publication from Meticulous Research®, the life science equipment
market is projected to reach $97.96
billion by 2031, at a CAGR of 6.3% during the forecast period. The growth of the life science equipment
is attributed to increasing funding and investment for the pharma, biotech, and
life sciences industries, government initiatives to strengthen R&D for
biotech and life sciences, increasing prevalence of chronic diseases, and
growing clinical capabilities globally.
Key Players
The key players operating in the life
science equipment market are Agilent Technologies, Inc. (U.S.), Becton,
Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher
Corporation (U.S.), F. Hoffmann LA-Roche AG (Switzerland), PerkinElmer, Inc.
(U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.),
Bruker Corporation (U.S.), Shimadzu Corporation (Japan), Siemens Healthineers
AG (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), and QIAGEN N.V.
(Netherlands).
Life Science Equipment Market:
Future Outlook
The life science equipment market is
segmented by Technology [Spectroscopy, Microscopy, Chromatography, Lab
Automation, Immunoassay Analyzers, PCR, Sequencing, Flow Cytometry, Incubators,
Microarray, Centrifuges, Electrophoresis, and Other Equipment], End User
[Pharmaceutical and Biotechnology Industry, Academic & Research Institutes,
Hospitals and Diagnostic Laboratories, Analytical Testing Laboratories,
Agriculture and Food Industry, Forensic Laboratories, and Other End Users) and
Geography. The study also evaluates industry competitors and analyzes the
market at the global and regional levels. (Note: Apart from primary
segmentation, Spectroscopy, Microscopy, Chromatography, Lab Automation,
Immunoassay Analyzer, PCR, Sequencing, Flow Cytometry, Microarray, Centrifuges,
and Electrophoresis have further level segmentation).
Among the technologies included in the
report, in 2024, the spectroscopy segment is expected to account for the
largest share of the life science equipment market. The segment's largest share
is contributed by factors such as advancements in spectroscopic technologies
and growing demand for analytical techniques coupled with increasing investment
in research and development activities in life sciences. Spectroscopy is used
for drug discovery, molecular analysis, protein characterization, metabolomics,
and other important research areas in life sciences. The increasing application
areas of spectroscopy is contributing to the segment's largest share.
Among the end users included in the
report, in 2024, the pharmaceutical and biotechnology industry segment is
expected to account for the largest share of the life science equipment market.
The largest share of the segment is attributed to the increasing demand for
technologically advanced equipment from pharmaceutical & biotechnology
companies as the demand for new therapies and drugs is increasing. Furthermore,
the pharmaceutical and biotechnology industries constantly strive to develop
new drugs and therapies to address medical needs. Developing new drugs and
therapies requires advanced laboratory equipment for drug discovery,
development, and production processes, including high-throughput screening
systems, chromatography systems, mass spectrometers, and other specialized
equipment. Hence, these factors drive the demand for life sciences and
laboratory equipment in the pharmaceutical and biotechnology industry.
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S. and
Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of
Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of
Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and
the Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East &
Africa)
In 2024, North America is expected to
account for the largest share of the life science equipment market, followed by
Europe and Asia-Pacific. Furthermore, in 2024, the U.S. is expected to be the
largest market in North America. The presence of key players, the
well-established life science industry, substantial spending on R&D
activities by the pharmaceutical and biotech companies, and the presence of key
players in the life sciences industry contribute to the large share of this
market. For instance, in 2021, Pharmaceutical Research and Manufacturers of
America (PhRMA) member companies spent USD 102.3 billion in R&D (Source:
2022 PhRMA member annual survey).
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3937
Key questions answered in the
report-
·
Which are
the high-growth market segments in terms of technology, end user, and
region/country?
·
What was
the historical market for life science equipment across the globe?
·
What are
the market forecasts and estimates for the period 2024–2031?
·
What are
the major drivers, restraints, challenges, opportunities, and trends in the
global life science equipment market?
·
Who are
the major players in the global life science equipment market?
·
How is the
competitive landscape, and who are the market leaders in the global life
science equipment market?
·
What are
the recent developments in the life science equipment market?
·
What are
the different strategies adopted by the major players in the life science
equipment market?
·
What are
the geographical trends and high growth regions/countries?
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment